Back
Middlefield Banc 10K Form
Buy
56
MBCN
Middlefield Banc
Last Price:
$27.70
Seasonality Move:
2.39%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-05-14 | 10Q | MBCN/Middlefield Banc Quarterly |
2023-11-13 | 10Q | MBCN/Middlefield Banc Quarterly |
2023-08-14 | 10Q | MBCN/Middlefield Banc Quarterly |
2023-05-15 | 10Q | MBCN/Middlefield Banc Quarterly |
2022-11-14 | 10Q | MBCN/Middlefield Banc Quarterly |
2022-08-08 | 10Q | MBCN/Middlefield Banc Quarterly |
Receive MBCN News And Ratings
See the #1 stock for the next 7 days that we like better than MBCN
MBCN Financial Statistics
Sales & Book Value
Annual Sales: | $67.9M |
---|---|
Cash Flow: | $2.3M |
Price / Cash Flow: | 13.87 |
Annual Sales: | $26.08 |
Price / Book: | 1.1 |
Profitability
EPS (TTM): | 1.92000 |
---|---|
Net Income (TTM): | $15.5M |
Gross Margin: | $0 |
Return on Equity: | 7.47% |
Return on Assets: | 0.85% |
Middlefield Banc Earnings Forecast
Key Middlefield Banc Financial Ratios
-
The Gross Profit Margin over the past 4 years for MBCN is 0.00%.
-
The Selling, General & Administrative Expenses for MBCN have been equal to 40.18% of Gross Profit Margin.
-
The Research & Development expenses have been 0.00% of Revenue.
-
The Interest Expense is 65.46% of Operating Income.
-
The Net Earning history of MBCN is 22.86% of Total Revenues.
-
Per Share Earnings over the last 25 years have been positive in 14 years.
Middlefield Banc Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Banks |
Sector: | Financials |
Current Symbol: | MBCN |
CUSIP: | 596304 |
Website: | middlefieldbank.bank |
Debt
Debt-to-Equity Ratio: | 0.86 |
---|---|
Current Ratio: | 1.29 |
Quick Ratio: | 1.23 |
Price-to-Earnings
Trailing P/E Ratio: | 14.92 |
---|---|
Forward P/E Ratio: | 13.74 |
MBCN Technical Analysis vs Fundamental Analysis
Buy
56
Middlefield Banc (MBCN)
is a Buy
Is Middlefield Banc a Buy or a Sell?
-
Middlefield Banc stock is rated a BuyThe current Middlefield Banc [MBCN] share price is $27.38. The Score for MBCN is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.